- Todos > Medicine Information and Evidence for Policy > Medicines Policy
- Todos > Medicine Programme Coordination > Programme Coordination
- Palabras clave > access to affordable essential medicines
- Palabras clave > access to essential medicines
- Palabras clave > affordable prices
- Palabras clave > availability, affordability, and quality of pharmaceutical products
- Palabras clave > EC/ACP/WHO partnership program
- Palabras clave > health system strengthening
- Palabras clave > pharmaceutical services - building capacity
- Palabras clave > policy perspectives
- Palabras clave > strategies
- Palabras clave > Strengthening Pharmaceutical Systems (SPS)
(2015; 8 pages) [French]
A population’s full and affordable access to quality essential medicines and treatment depends on a number of factors: efficient regulation, provision and supply of medicines; sound policies on selection and use; affordable pricing; a qualified health workforce; information systems; functioning health infrastructure; and good governance. Many countries in sub-Saharan Africa do not meet these criteria, largely due to resource constraints, and struggle to provide quality essential medicines to their populations. This, coupled with a heavy burden of infectious and other diseases, results in high levels of illness and death, two of the main causes of low human and economic development.
To address some of the access barriers in sub-Saharan Africa, the European Union (EU) has invested Euro 10 million into a four-year effort to boost the pharmaceutical system in 15 sub-Saharan African countries. The project benefits from support from the African Caribbean and Pacific Group of States Secretariat (ACP) and relies on the World Health Organization’s (WHO’s) expertise to transfer knowledge and provide guidance and training to pharmacists and healthcare policy makers.